Introduction
The number of product information sites provided to consumers in the EU is limited, while disease and public education sites are abundant and are used to effectively target consumers, and sites targeting healthcare professionals in the EU are readily available. Sites must be optimized to of influence their target audiences, and to attract, convert and retain these important decision makers.
Scope
- Assess and compare the value of 18 leading pharmaceutical companies’ web presence across a number of criteria
- Identify which tools are needed to encourage European consumers and healthcare professionals to revisit a website and to drive new users to the site
- Identify how pharmaceutical companies provide information to European consumers without directly advertising their brand
Highlights
Reasons to Purchase
Other selected research from the 'Europe' category:
European Biotech Industry Guide 2007, 5th Ed.
This exciting intelligence CD-ROM on European biotech industry has become better, stronger and more intelligent in its 5th Edition. Learn More
Pharmaceuticals: Europe Industry Guide
Datamonitor’s Pharmaceuticals: Europe Industry Guide is an essential resource for top-level data and analysis covering the Europe Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual... Learn More
Other selected research from the 'IT & eHealth' category:
Handhelds in Healthcare: The World Market for PDAs, Tablet PCs, Handheld Monitors & Scanners
This Kalorama Information report - The Global Handheld Healthcare Device Market - focuses on two primary segments of healthcare IT: -Patient Monitoring Devices, including: - Blood pressure devices - Pulse oximeters - ECG/EKG monitors... Learn More
eDetailing: Reducing Costs and Improving the Effectiveness of the Detailing Process
The quality of detailing sessions is dropping due to the increasingly limited time sales representatives have with physicians. To help address this problem and reverse the decline in detailing productivity, technology-based solutions, such as eDetailing, have arisen. If used appropriately, eDetailing can offer physicians high-quality information in a convenient and interactive format. Learn More
Other selected research from the 'Pharmacoeconomics' category:
Direct-to-Consumer Advertising Regulations in the US: What are the implications for the eHealth market?
Public perception of the US pharmaceutical industry is at an all-time low. Enhanced safety warnings attached to some drugs and the complete market withdrawal of others have undermined consumer confidence in both the industry and the products it produces. These doubts pose an imminent danger to an industry that will have to rely increasingly on word-of-mouth to create brand awareness and loyalty. Learn More
Beyond the Blockbuster Drug: Strategies for nichebuster drugs, targeted therapies and personalized medicine.
This report examines targeted therapies and targeted drug delivery strategies as alternative investment options for pharmaceutical companies, in the face of declining returns and slow growth in the blockbuster market. Learn More